Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

MM19: Potential Long-term Sequelae of COVID-19

In this presentation, Dr. Wong Chen Seong discusses what is known about COVID-19 symptom persistence and the long-term pulmonary, cardiovascular, and neurologic sequelae in recovered patients
person default
Dr Wong Chen Seong
Released: September 25, 2020

Information on this Educational Activity

Faculty

Dr Wong Chen Seong

Adjunct Assistant Professor
Department of Medicine
Yong Loo Lin School of Medicine
National University of Singapore
Consultant
Department of Infectious Diseases
National Centre for Infectious Diseases and Tan Tock Seng Hospital
Singapore

Wong Chen Seong, MBBS, MRCP(UK), FAMS, has disclosed that he has received consulting fees from Gilead Sciences and GlaxoSmithKline.

Program Medium

This program has been made available online.

Related Content

Download free slides from CCO reviewing the latest data and guidance on COVID-19 symptoms and the prevalence and duration of natural immunity

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Download free slides from CCO reviewing the latest data and guidance on COVID-19 risk and management in special populations and persons with comorbidities

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Download free slides from CCO reviewing the latest updates on COVID-19 epidemiology and emerging data on diagnosis and transmission

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021

Download free slides from CCO reviewing the latest data and guidance on COVID-19 treatments, including authorized and investigational agents

Ada Adimora, MD, MPH David Heymann, BA, MD, DTM&H Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Jens D. Lundgren, MD, DMSc Vikramjit Mukherjee, MD Roger Paredes, MD, PhD Leo Yee-Sin, MBBS, MPH, MRCP, FRCP, FAMS Released: March 26, 2021
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by
Gilead Sciences, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue